HIFU FDA Application Stalled For Now

FDA Panel Doesn’t Recommend Device To Help Treat Recurrent Prostate Cancer. Medscape (10/3) reports and FDA advisory committee voted Oct. 1 “not to recommend approval, at least for now, of a high-intensity focused ultrasound (HIFU) device to treat some patients with recurrent prostate cancer.” The piece notes that the members of the Gastroenterology and Urology [...]